These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1005735)

  • 1. Failure of indomethacin to reduce hypercalcemia in patients with breast cancer.
    Coombes RC; Neville AM; Bondy PK; Powles TJ
    Prostaglandins; 1976 Dec; 12(6):1027-35. PubMed ID: 1005735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone collagen and calcium metabolism in normocalcemic and hypercalcemic patients with breast cancer.
    Lee CA; Lloyd HM
    Cancer; 1971 May; 27(5):1099-105. PubMed ID: 5092517
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer.
    Seyberth HW; Segre GV; Morgan JL; Sweetman BJ; Potts JT; Oates JA
    N Engl J Med; 1975 Dec; 293(25):1278-83. PubMed ID: 1186822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stimulation of calcium reabsorption observed in advanced breast cancer patients with hypercalcemia and multiple bone metastases.
    Kimura S; Adchi I; Yamaguchi K; Suzuki M; Shimada A; Sato Y; Nagaoka K; Abe K
    Jpn J Cancer Res; 1985 Apr; 76(4):308-14. PubMed ID: 2989061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer.
    Powles TJ; Clark SA; Easty DM; Easty GC; Neville AM
    Br J Cancer; 1973 Oct; 28(4):316-21. PubMed ID: 4759939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium metabolism in breast cancer.
    Coombes RC; Powles TJ; Joplin DG
    Proc R Soc Med; 1977 Mar; 70(3):195-9. PubMed ID: 870901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of aspirin and indomethacin on the serum and urinary calcium, magnesium and phosphate.
    Gomaa AA; Hassan HA; Ghaneimah SA
    Pharmacol Res; 1990; 22(1):59-70. PubMed ID: 2330339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypercalcemia in breast cancer.
    Francini G; Petrioli R; Maioli E; Gonnelli S; Marsili S; Aquino A; Bruni S
    Clin Exp Metastasis; 1993 Sep; 11(5):359-67. PubMed ID: 8375111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aspirin inhibition of 1 alpha-hydroxyvitamin D3 or parathyroid hormone induced hypercalcemia in vivo in rats. A mechanism independent of prostaglandin biosynthesis inhibition.
    Kawashima H; Kurozumi S; Hashimoto Y
    Biochem Pharmacol; 1985 Jun; 34(11):1901-6. PubMed ID: 4004906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Breast cancer-associated hypercalcaemia: a reassessment of renal calcium and phosphate handling.
    Gallacher SJ; Fraser WD; Patel U; Logue FC; Soukop M; Boyle IT; Ralston SH
    Ann Clin Biochem; 1990 Nov; 27 ( Pt 6)():551-6. PubMed ID: 1964370
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma prostaglandin E in patients with cancer with and without hypercalcemia.
    Robertson RP; Baylink DJ; Metz SA; Cummings KB
    J Clin Endocrinol Metab; 1976 Dec; 43(6):1330-5. PubMed ID: 1002818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mithramycin treatment of intractable hypercalcemia due to parathyroid carcinoma.
    Singer FR; Neer RM; Murray TM; Keutmann HT; Deftos LJ; Potts JT
    N Engl J Med; 1970 Sep; 283(12):634-6. PubMed ID: 5450637
    [No Abstract]   [Full Text] [Related]  

  • 13. Breast-cancer osteolysis, bone metastases, and anti-osteolytic effect of aspirin.
    Powles TJ; Dowsett M; Easty GC; Easty DM; Neville AM
    Lancet; 1976 Mar; 1(7960):608-10. PubMed ID: 55892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphaturia in hypercalcemic breast cancer patients.
    Schussler GC; Verso M; Nemoto T
    J Clin Endocrinol Metab; 1972 Oct; 35(4):497-504. PubMed ID: 5052972
    [No Abstract]   [Full Text] [Related]  

  • 15. Elevated prostaglandins and suppressed parathyroid hormone associated with hypercalcemia and renal cell carcinoma.
    Robertson RP; Baylink DJ; Marini BJ; Adkison HW
    J Clin Endocrinol Metab; 1975 Jul; 41(1):164-7. PubMed ID: 1150858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of osteolytic bone lesions by (3-amino-1-hydroxypropylidene)-1, 1-bisphosphonate (A.P.D.).
    van Breukelen FJ; Bijvoet OL; van Oosterom AT
    Lancet; 1979 Apr; 1(8120):803-5. PubMed ID: 86043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium homeostasis and the patogenesis and management of hypercalcemic disorders.
    Schneider AB; Sherwood LM
    Metabolism; 1974 Oct; 23(10):975-1007. PubMed ID: 4369823
    [No Abstract]   [Full Text] [Related]  

  • 18. Increased prevalence of primary hyperparathyroidism in treated breast cancer.
    Fierabracci P; Pinchera A; Miccoli P; Conte PF; Vignali E; Zaccagnini M; Marcocci C; Giani C
    J Endocrinol Invest; 2001 May; 24(5):315-20. PubMed ID: 11407650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous pamidronate in patients with tumor-induced osteolysis: a biochemical dose-response study.
    Body JJ; Dumon JC; Piccart M; Ford J
    J Bone Miner Res; 1995 Aug; 10(8):1191-6. PubMed ID: 8585422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of malignant hypercalcaemia in carcinoma of the breast.
    Percival RC; Yates AJ; Gray RE; Galloway J; Rogers K; Neal FE; Kanis JA
    Br Med J (Clin Res Ed); 1985 Sep; 291(6498):776-9. PubMed ID: 3929936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.